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A leptin-regulated circuit controls glucose mobilization
during noxious stimuli
Jonathan N. Flak,1 Deanna Arble,2 Warren Pan,1,3 Christa Patterson,1 Thomas Lanigan,1 Paulette B. Goforth,4 Jamie Sacksner,1
Maja Joosten,5 Donald A. Morgan,6 Margaret B. Allison,1,7 John Hayes,8 Eva Feldman,8 Randy J. Seeley,2 David P. Olson,9
Kamal Rahmouni,6 and Martin G. Myers Jr.1,2,7
Department of Internal Medicine, 2Department of Surgery, 3Graduate Program in Cellular and Molecular Biology, and 4Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA.

1

Radboud University, Nijmegen, Netherlands. 6Department of Pharmacology, University of Iowa, Iowa City, Iowa, USA. 7Department of Molecular and Integrative Physiology,

5

Department of Neurology, and 9Division of Endocrinology, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.

8

Adipocytes secrete the hormone leptin to signal the sufficiency of energy stores. Reductions in circulating leptin
concentrations reflect a negative energy balance, which augments sympathetic nervous system (SNS) activation in
response to metabolically demanding emergencies. This process ensures adequate glucose mobilization despite low energy
stores. We report that leptin receptor–expressing neurons (LepRb neurons) in the periaqueductal gray (PAG), the largest
population of LepRb neurons in the brain stem, mediate this process. Application of noxious stimuli, which often signal the
need to mobilize glucose to support an appropriate response, activated PAG LepRb neurons, which project to and activate
parabrachial nucleus (PBN) neurons that control SNS activation and glucose mobilization. Furthermore, activating PAG
LepRb neurons increased SNS activity and blood glucose concentrations, while ablating LepRb in PAG neurons augmented
glucose mobilization in response to noxious stimuli. Thus, decreased leptin action on PAG LepRb neurons augments the
autonomic response to noxious stimuli, ensuring sufficient glucose mobilization during periods of acute demand in the face
of diminished energy stores.

Introduction

The hormone leptin, which is produced by adipocytes to signal the
repletion of body energy (fat) stores, acts via the leptin receptor
(LepRb) on specialized populations of brain neurons to control
food intake, energy expenditure, and other metabolic parameters
(1–4). The fall in circulating leptin concentrations during negative
energy balance increases hunger and initiates an energy-sparing
neuroendocrine program characterized by decreased sympathetic
nervous system (SNS) tone and diminished activity of the thyroid,
reproductive, and growth axes, among others. This response not
only tends to replenish body energy stores by increasing feeding
relative to energy utilization when food is available, but also preserves remaining energy stores in the face of continued famine,
increasing the chances of survival until food becomes available.
The withdrawal of leptin action from LepRb neurons in the
hypothalamus mediates most of these orexigenic and energysparing responses to negative energy balance (5). While brain stem
sites contain many LepRb neurons, roles for most populations of
brain stem LepRb neurons, including the largest population (located in the periaqueductal gray [PAG]), remain undefined (6, 7).
In isolation, the energy-sparing neuroendocrine response
to negative energy balance carries a potential risk, however. The
reduction of energy stores coupled with decreased SNS tone
impairs the ability to respond to acute, potentially life-threatening
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emergencies that require the robust mobilization of metabolic
fuels, such as glucose. Thus, during negative energy balance,
meeting acutely elevated metabolic needs requires a system
that increases the drive to mobilize glucose beyond that which is
required when energy reserves are replete. Furthermore, this system must activate specifically in response to metabolic emergencies without otherwise altering SNS tone and glucose mobilization
(otherwise, this would blunt the energy-sparing response to negative energy balance). Indeed, we previously defined a system that
augments the counterregulatory response (CRR) to hypoglycemia
when energy stores are diminished: hypoglycemia activates cholecystokinin-containing (CCK-containing) neurons in the hindbrain
parabrachial nucleus (PBN), which project to the ventromedial
hypothalamic nucleus (VMN) (which plays a crucial role in the
CRR) (8, 9). Some PBN CCK neurons contain LepRb; during negative energy balance, the withdrawal of leptin from these PBN LepRb cells augments their response to low glucose, enhancing glucose mobilization during hypoglycemia without altering baseline
endocrine function, energy balance, or glucose homeostasis (8).
We reasoned that other stimuli that signal the need for robust
SNS activation and glucose mobilization might similarly engage
the PBN→VMN circuit to meet acutely increased metabolic
demands when energy stores are low. Because noxious stimuli
(such as pain) increase blood glucose and often indicate the need
for SNS activation and nutrient mobilization, we sought to understand the potential role for hindbrain LepRb neurons in modulating the response to noxious stimuli in line with the repletion state of
body energy stores. We find that LepRb neurons in the PAG (which
plays crucial roles in responding to noxious stimuli; refs. 10–13) lie
jci.org   Volume 127   Number 8   August 2017
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Figure 1. Hyperglycemic and c-Fos responses to noxious stimuli. (A) Ad libitum–fed (n = 10) and overnight-fasted (n = 8) C57BL/6 mice were injected with
intra–hind paw formalin (5%, 20 μl), and blood glucose concentrations were measured over the subsequent 3 hours. Data are plotted as mean ± SEM. (B)
LepRbeGFP-L10a mice were treated with (C, D, G, H) intra–hind paw formalin (n = 4, veh; n = 5, formalin) as in A or (E, F, I, J) 2DG (n = 5, veh; n = 4, 2DG) (500
mg/kg, i.p.) and perfused under anesthesia. Brains were collected and sectioned; sections were stained for c-Fos (DAB, purple) and GFP (green). Images (C,
E, G, I) are representative of 4–5 similar animals for each treatment. Graphs show colocalized cells/total LepRb cells, plotted as percentage, mean ± SEM.
*P < 0.05. Scale bars: 100 μm. Data in panel A were analyzed by 2-way repeated-measures ANOVA with Fisher’s LSD post hoc test, and data in panels D, F,
H, and J were analyzed by 1-tailed t test.

upstream of the PBN→VMN circuit. Diminished leptin action on
these LepRbPAG neurons augments the hyperglycemic response to
noxious stimuli, ensuring appropriately elevated autonomic output to mediate sufficient glucose mobilization in response to acute
metabolic need under conditions of negative energy balance.

Results

Noxious stimuli activate LepRb neurons in the PBN and PAG. Pain
and other noxious stimuli activate the SNS and promote the mobilization of metabolic fuels to support the ability to cope with the
stimulus-evoking event. Thus, short-term survival when faced
with a noxious stimulus during negative energy balance requires a
brain system that can overcome low SNS tone and depleted energy stores to support nutrient mobilization. Indeed, a 12-hour fast
enhances the hyperglycemic response to the injection of 5% formalin into the footpad of the hind paw (a common noxious stimulus model; refs. 14–16) (Figure 1A).
Since the withdrawal of leptin from leptin-inhibited LepRb
neurons in the PBN (LepRbPBN cells) enhances SNS activation
and glucose mobilization during hypoglycemia (8), mitigating the
impairment of the CRR that would otherwise occur during negative energy balance, we sought to determine whether the LepRbPBN
circuitry might similarly modulate the response to noxious stimuli. We thus examined the potential activation of LepRbPBN cells
3104
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by noxious stimuli, using the criterion of immunohistochemically
detectable c-Fos induction in LeprCre Rosa26L10a-GFP (LepRbL10a-GFP;
ref. 17) mice (Figure 1B), which express an L10a-GFP fusion protein in LepRb neurons, enabling their detection by αGFP immuno
histochemistry (Figure 1 and Supplemental Figure 1; supplemental material available online with this article; https://doi.org/
10.1172/JCI90147DS1). Indeed, in LepRbL10a-GFP mice, formalin
injection into the footpad promoted c-Fos accumulation in 38%
of LepRbPBN neurons (562 ± 23 cells, mean ± SEM; n = 5) (Figure
1, C and D), similar to the effect of glucoprivation by the injection of 2-deoxyglucose (2DG) (which mimics hypoglycemia at
the cellular level) on these cells (568 ± 6 cells, mean ± SEM; n = 3)
(Figure 1, E and F), suggesting that LepRbPBN neurons might play
a role in modulating the response to noxious stimuli, in addition
to hypoglycemia, during negative energy balance. Additionally,
formalin injection activated approximately 23% of the LepRb neurons (1862 ± 106 cells, mean ± SEM; n = 5) in the neighboring PAG
(LepRbPAG neurons) (Figure 1, G and H), although glucoprivation
did not activate LepRbPAG cells (Figure 1, I and J).
Integration of LepRbPAG neurons with the PBN→VMN circuit.
Because noxious stimulus exposure activates both LepRbPAG and
LepRbPBN neurons (while glucoprivation activates only LepRbPBN
cells), and since the PAG receives and integrates signals related
to noxious stimuli, we hypothesized that LepRbPAG neurons might
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Figure 2. PAGLepRb neurons project to the PBN. (A) LeprCre mice were injected with AAV-Syn-GFP into the PAG and AAV-map2c-dsRed into the PBN. The
mice were perfused; (B and C) brains were collected, sectioned, and stained for GFP (green) and dsRed (red). Images are representative of 3 similar cases.
Dashed lines indicate the boundaries of the PAG and PBN. Box in B shows the zoomed-in area represented in C. (D) LeprCre/eYFP mice were injected with
AAV-TVA+G into the PAG; 2 weeks later, defective pseudotyped mCherry-expressing rabies virus (Rabies-ΔG-mCherry) was injected into the PBN. Five
days later, mice were perfused and brains were collected and sectioned. Brain sections were stained for GFP (green) and dsRed (red) (E and F). Images are
representative of 4 similar cases. H shows an enlarged image of G. Scale bars: 100 μm. IC, inferior colliculus; Aq, cerebral aqueduct.

represent the means by which information regarding noxious
stimuli enters the PBN→VMN circuit. To test this, we injected
AAV-SynGFP (which mediates the Cre-inducible expression of a
synaptophysin-GFP fusion protein to reveal synaptic terminals)
into the PAG of LeprCre mice; at the same time, we injected AAVmap2c-dsRed (which mediates the Cre-inducible expression of
a map2c-dsRed fusion protein that identifies the dendritic tree)
into the PBN of the same mice (Figure 2A). This revealed the projection field of LepRbPAG neurons, which densely innervate the
PBN, and demonstrated that many of the synaptic terminals from
these cells lie in the PBN region that contains the dendritic tree of
LepRbPBN neurons (Figure 2, B and C). We also found terminals
from LepRbPAG neurons in the dorsomedial nucleus of the hypothalamus (DMH) and dorsomedial thalamus (Supplemental Figure 2), although these were much sparser than those in the PBN.
We employed rabies-mediated monosynaptic retrograde tracing (18) to examine the circuitry of PBN-projecting LepRbPAG cells.
In this system, the injection of the AAV-TVA+G helper virus mediates expression of TVA in Cre-containing neurons to permit their
infection by a pseudotyped, G-deleted, mCherry-expressing rabies
virus (Rabies-ΔG-mCherry). AAV-TVA+G also mediates the Credependent expression of G, enabling the passage of Rabies-ΔGmCherry one synapse retrograde to the Cre-expressing neuron.
We injected AAV-TVA+G into the PAG of LeprCre-eYFP mice and then
delivered Rabies-ΔG-mCherry into the PBN (Figure 2, D–H). This
not only infected many LepRbPAG cells with Rabies-ΔG-mCherry
(consistent with our identification of the PBN as a major projection
target of LepRbPAG cells), but also revealed numerous Rabies-ΔG-

mCherry–containing local afferents of PBN-projecting LepRbPAG
cells, especially in the PAG. We also observed afferents to the
LepRbPAG→PBN circuit in more distant sites, including the dorsal
raphe (DR) (Supplemental Figure 3); we observed few afferents
elsewhere and none in the spinal cord, suggesting little or no direct
input from peripheral nociceptive neurons. Thus, most of the neural signals to the LepRbPAG→PBN circuit enter via other PAG cells.
Since LepRbPAG cells project to the PBN and contain stimulatory neurotransmitters (such as Glu and CCK), activation of
LepRbPAG cells should stimulate neurons in the PBN. To test this,
we utilized AAV-hMD3q, which mediates the Cre-dependent
expression of the Gq-coupled designer receptor exclusively activated by designer drugs (DREADD), permitting the clozapine-Noxide–stimulated (CNO-stimulated) activation of Cre-expressing
neurons in the region where the virus is injected. We injected
AAV-hMD3q separately into the PAG or PBN of LeprCre mice and
examined the induction of c-Fos in these regions following the
administration of CNO (Supplemental Figure 4). CNO treatment
of PAG-injected mice promoted the accumulation of c-Fos in the
PAG and PBN, while CNO promoted robust c-Fos accumulation
in the PBN of PBN-injected mice, but little in the PAG. Thus,
LepRbPAG neurons lie afferent to and stimulate PBN neurons.
To determine whether PAG neurons, including LepRbPAG cells,
lie in direct synaptic contact with the LepRbPBN→VMN circuit, we
injected AAV-TVA+G into the PBN of LepRbL10a-GFP mice, followed
by the injection of Rabies-ΔG-mCherry into the VMN to mediate the infection of VMN-projecting LepRbPBN (LepRbPBN→VMN)
neurons specifically and to label the cells that lie 1 synapse afferjci.org   Volume 127   Number 8   August 2017
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Figure 3. PAGLepRb neurons innervate VMN-projecting PBNLepRb neurons. (A) LepRbeGFP-L10a mice were injected with AAV-TVA+G into the PBN, followed by defective pseudotyped mCherry-expressing rabies virus (Rabies-ΔG-mCherry) injection into the VMN. Five days later, the mice were perfused, and brains were collected, sectioned, and stained for GFP (green) and dsRed (red) (B–D). Shown are images representative of 4 similar cases: (B) PAG, PBN, and surrounding areas
(mCherry only); (C) PBN (merged image); (D) PAG (merged image). Dashed lines in B denote the boundaries of the PAG and PBN. Scale bars: 100 μm.

ent to these cells (Figure 3A). This analysis revealed Rabies-ΔGmCherry–infected cells in the PBN as well as identifying afferents
of LepRbPBN→VMN neurons in the PAG and in several other nearby
areas (Figure 3B). We also observed afferents of LepRbPBN→VMN
neurons in more distal regions, including the DR, the paraventricular nucleus of the hypothalamus, the bed nucleus of the stria
terminalis, and the central nucleus of the amygdala (CeA) (Supplemental Figure 5). In addition to demonstrating the expected
infection of many GFP-containing LepRbPBN cells by intra-VMN
Rabies-ΔG-mCherry (Figure 3C), some (<10%) of the PAG neurons afferent to the LepRbPBN→VMN cells contained GFP (Figure
3D), revealing that LepRbPAG neurons are among the PAG cells that
project to and synapse on VMN-projecting LepRbPBN cells.
LepRbPAG neurons activate the SNS and increase blood glucose.
Taken as a whole, our data suggest that LepRbPAG cells project to
and activate neurons in the PBN→VMN circuit, implying that
activating LepRbPAG neurons should mimic the CRR, activating
the SNS and increasing blood glucose concentrations. To determine the physiologic and behavioral responses to the activation of
LepRbPAG and LepRbPBN cells, we injected AAV-hMD3q into the
PAG or PBN of LeprCre mice and examined their responses to CNO
(Figure 4A). We observed 1663 ± 364 (mean ± SEM; n = 7) PBN
hM3Dq-expressing cells and 2853 ± 422 (mean ± SEM; n = 9) PAG
hM3Dq-expressing cells in our study. We initially observed that
activation of either set of LepRb neurons increased locomotor
activity (Supplemental Figure 6), consistent with increased SNS
drive following the activation of these cells. Indeed, CNO administration to mice expressing hMD3q either in LepRbPBN or LepRbPAG
cells increased adrenal sympathetic nerve activity (SNA) (Figure 4,
B and C), although the activation mediated by the LepRbPBN neurons became statistically significant at earlier times than for the
LepRbPAG neurons. Furthermore, activation of LepRbPAG or
LepRbPBN neurons increased blood glucose concentrations (Figure 4, D and E). Thus, LepRbPAG neurons, like LepRbPBN cells, promote SNS activity and increased blood glucose — consistent with
a role for LepRbPAG neurons in controlling glucose mobilization in
response to activating stimuli (e.g., noxious stimuli).
Hypercapnia normally signifies an increase in cellular respiration/metabolic demand that is not appropriately compensated
by breathing; the PAG participates in the ventilatory response to
hypercapnia (19–22). To determine whether LepRbPAG neurons
might also participate in other autonomic responses to poten3106
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tially noxious stimuli that reflect increased metabolic demand,
we examined the ventilatory response to hypercapnia in animals expressing hM3Dq in LepRbPAG neurons (Figure 4F). CNO
administration increased breathing frequency in 3% CO2, but not
in room air, consistent with augmented SNS drive to respiratory
centers. Thus, in addition to increasing SNS outflow to the adrenal gland and elevating blood glucose concentrations, activation
of LepRbPAG cells augments the ventilatory response to hypercapnia, consistent with a role for these cells in promoting appropriate
autonomic responses when metabolic demand is acutely elevated.
Ablation of LepRb from the PAG augments the hyperglycemic
and ventilatory responses to noxious stimuli. To determine whether
leptin action via brain stem LepRb neurons modulates glucose
mobilization in response to noxious stimuli, we evaluated the
hyperglycemic responses to noxious stimuli in LepRbCCKKO mice
(CckCre Leprfl/fl), in which LepRb is ablated from CCK-expressing
brain stem neurons (including LepRbPBN cells, a substantial number of LepRbPAG neurons, and a smaller number of LepRb neurons
in the Edinger-Westfall [EW] nucleus) (8) (Figure 5A). As we previously showed (8), the hyperglycemic response to glucoprivation
is accentuated and prolonged in LepRbCCKKO mice (Figure 5B),
consistent with the role for LepRbPBN neurons in augmenting the
CRR to glucoprivation when leptin action is low. Furthermore,
LepRbCckKO mice demonstrated an exaggerated hyperglycemic
response to formalin injection, revealing that decreased leptin
action on LepRbCCK neurons augments glucose mobilization in
response to noxious stimuli (Figure 5C).
Since leptin action in LepRbCCKKO mice is only partially interrupted in the PAG and is also ablated in the EW and PBN (8), we
sought to determine the role of PAG leptin action specifically in
the response to noxious stimuli. We thus injected AAV-Cre or
AAV-mCherry (control) into the PAG of Leprfl/fl mice, disrupting
LepRb specifically in the PAG (LepRbPAGKO mice) to reveal the
role of LepRbPAG neurons in leptin action (Figure 6A and Supplemental Figure 7). Food intake, body weight, glucose tolerance,
insulin-induced hypoglycemia, and the hyperglycemic response
to glucoprivation were not altered in LepRbPAGKO mice (Figure 6,
B–F), consistent with the notion that LepRbPBN cells (rather than
LepRbPAG neurons) augment the CRR to hypoglycemia/glucoprivation when leptin action is decreased.
The hyperglycemic response to formalin injection was significantly enhanced in LepRbPAGKO mice, however, revealing that

Downloaded from http://www.jci.org on November 15, 2017. https://doi.org/10.1172/JCI90147

RESEARCH ARTICLE

The Journal of Clinical Investigation  

Figure 4. Activation of PAGLepRb increases adrenal SNA,
blood glucose, and respiratory responses to hypercapnia.
(A) LeprCre (CC) animals were injected with AAV-hM3Dq
into the PBN (left panels) or PAG (right panels). (B and C)
PBN (B) (n = 8, C57BL/6 [C57]; n = 6, CC) and PAG (C)
(n = 7, C57BL/6; n = 9, CC) AAV-hM3Dq–injected C57BL/6
or LeprCre (Cre) animals were treated with CNO during SNA
recording. Data were broken down into 5-minute bins for
analysis; data are plotted as mean ± SEM; *P < 0.05. (D
and E) PBN (D) or PAG (E) AAV-hM3Dq–injected LeprCre mice
were injected with either CNO or vehicle and blood glucose
sampled. Data are presented as mean ± SEM; *P < 0.05.
(F) PAG-injected LeprCre mice were treated with either CNO
or vehicle, and respiratory frequency was monitored at
baseline and during exposure to 3% CO2 in a whole-body
plethysmograph. Data are plotted as mean ± SEM; *P <
0.05. Data in panels B–E were analyzed by 2-way repeatedmeasures ANOVA with Fisher’s LSD post hoc test. Data in
panel F were analyzed using a 1-tailed t test.

a constitutive AAV-TetTOX-GFP (which expresses
tetanus toxin, preventing neurotransmitter release
and effectively silencing all PBN neurons, plus GFP)
in mice that also received injections of AAV-hM3Dq
in the PBN of LeprCre mice (Figure 7A. As previously,
CNO increased blood glucose concentrations in mice
expressing hM3Dq in LepRbPAG neurons plus control
virus in the PBN (Figure 7, B and C). In contrast, the
hyperglycemic effect of CNO was diminished in
mice expressing hM3Dq in LepRbPAG neurons plus
AAV-TetTOX-GFP in the PBN. Thus, PBN-mediated
neurotransmission plays a crucial role in the control
of blood glucose by LepRbPAG neurons.
Thus, the withdrawal of leptin action from
LepRbPAG cells enhances glucose mobilization and
other autonomic responses to noxious stimuli (pain,
hypercapnia) that signal acutely increased metabolic demand, consistent with a crucial role for these
cells in the brain system that promotes adequate
glucose mobilization and SNS activity when metabolic requirements increase acutely during negative
energy balance (Figure 7D).
decreased leptin action on LepRbPAG cells enhances glucose mobilization during noxious stimuli (Figure 6G). Importantly, however,
measures of pain perception and sensitivity were not altered in
LepRbPAGKO mice (Supplemental Figure 8), indicating that leptin
action via the PAG controls glucose mobilization during noxious
stimuli, but does not alter the threshold for noxious stimulus perception. Furthermore, the breathing frequency of LepRbPAGKO
mice was not different from that of controls in room air, but
increased compared with control animals in the presence of 3%
CO2 (Figure 6H), consistent with the notion that decreased leptin
action on LepRbPAG cells enhances the autonomic hyperventilatory
response to hypercapnia.
Our tracing experiments (Figures 2 and 3) suggest that projections from LepRbPAG cells to the PBN could mediate the actions of
these cells. To test this directly, we injected control AAV-GFP or

Discussion

We have identified a role for low leptin during negative energy
balance in augmenting the autonomic response to noxious stimuli
that signify acute unmet metabolic needs, thus ensuring that the
drive to mobilize glucose is sufficient to overcome the additive
effects of low SNS tone and depleted body energy stores (Figure
1A). Hence, this system can mitigate the detrimental effects of
what would otherwise be diminished glucose mobilization during
metabolic challenges in the face of the low SNS tone and depleted
energy reserves that accompany negative energy balance.
Our findings also reveal the neural circuit that mediates this
function (Figure 7D), beginning with LepRbPAG neurons — the
largest group of LepRb neurons in the brain stem, whose function
was previously unknown (6, 8). Noxious stimuli (which indicate
the need to mobilize glucose to support appropriate responses)
jci.org   Volume 127   Number 8   August 2017
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Figure 5. LepRbCCKKO mice exhibit exaggerated hyperglycemic
responses to formalin injection. (A) LepRbCCKKO mice were generated by crossing CckCre onto the Leprfl background. (B) Leprfl/fl
(control) (n = 12) and LepRbCCKKO (n = 10) mice were treated with
2DG (500 mg/kg, i.p.) and monitored for blood glucose. (C) A separate group of animals was treated with intra–hind paw formalin
(5%, 20 μl) (n = 17, control; n = 13, LepRbCCKKO), and blood glucose
was monitored. Data are plotted as mean ± SEM; *P < 0.05. Data
in panels B and C were analyzed with 2-way repeated-measures
ANOVA with Fisher’s LSD post hoc test.

activate LepRbPAG neurons, which project to the PBN→VMN circuit and promote SNS outflow and glucose mobilization. The
withdrawal of leptin action from LepRbPAG cells enhances glucose
mobilization in response to noxious stimuli, revealing a role for
these cells in ensuring adequate glucose mobilization in response
to acute demands when leptin levels are low due to negative energy balance. In addition to the obvious survival benefit conferred
by this system in the wild, it may also complicate the analysis of
glycemic control, especially by inexperienced researchers who
inadvertently provoke noxious stimuli while measuring blood glucose in fasted or leptin-deficient animals.
Interestingly, the time course with which the hM3Dq-mediated
activation of LepRbPAG neurons augments blood glucose is delayed
relative to some acute sympathetic responses to noxious stimuli
(such as those that increase heart rate and blood pressure). This
finding may indicate that the negative energy balance–mediated
augmentation of glucose mobilization in response to noxious stimuli operates via a different, more slowly acting system and thus with
a delayed time course compared with these other parameters. This
would suggest that LepRbPAG neurons and their circuits play more
important roles in response to stimuli that develop over or last for
many minutes, thus indicating the need for more sustained glucose
mobilization (rather than mediating the immediate response to
noxious stimuli that might be adequately met with an initial burst
of SNS activation). Alternatively, activation of LepRbPAG neurons or
the circuits they subserve might require other contextual cues to
mediate the more immediate augmentation of blood glucose.
Since activating LepRbPAG neurons or ablating LepRb in these
cells also augments the ventilatory response to hypercapnia
(which signals high metabolic demand relative to ventilation),
LepRbPAG cells presumably match ventilatory drive to the needs of
acutely increased metabolic demand when leptin levels are low.
These functions for LepRbPAG cells are consistent with the general
role for the PAG in mediating sympathetic activation (23–25) and
many autonomic responses to pain (12, 26) as well as the control of
respiratory rate and the response to hypercapnia (19–22).
The PAG is a large nucleus, different regions of which play
relatively distinct roles in autonomic and behavioral control. The
3108
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ventral PAG receives projections primarily from the spinal cord and
brain stem and mediates passive coping responses, such as freezing
and decreasing blood pressure (25, 26). In contrast, the dorsal PAG
(especially the caudal dorsal PAG) receives projections from sensory processing centers and mediates active coping responses, such
as increased SNS output and flight (23–26). The majority of the PAG
LepRb cells lie within this caudal dorsal region of the PAG, which
also contains the vast majority of noxious stimulus–activated LepRb
neurons. Due to the size of the PAG, it is not possible to target the
entire length and depth of this nucleus by injection; we focused on
the caudal dorsal regions with our injections, using 2 injections per
side (4 injections total per mouse) to sufficiently target the relevant
populations of LepRbPAG neurons. The role of LepRbPAG cells in promoting SNS outflow, activity, glucose mobilization, and increased
respiratory rate are consistent with the known output of this region.
Since LepRb neurons in other areas of the PAG (and in adjoining
structures, such as the DR) could mediate distinct processes, it will
be interesting to define their functions as well.
This LepRbPAG→PBN→VMN circuit demonstrates multiple
levels of specificity. Since it is engaged by the removal of leptin
action, it is activated specifically during negative energy balance, when it is required to augment the drive to mobilize glucose. Also, it is activated only during times of acute need (i.e., it
does not augment glucose mobilization in the absence of a noxious stimulus or another inciting event). Furthermore, the overall
LepRbPAG→PBN→VMN system is specific for stressors that indicate an acute metabolic challenge (e.g., noxious stimuli, elevated
CO2, or in the case of the PBN, glucoprivation); this system is not
activated during restraint stress (8) or in response to acute hypotension (data not shown), for instance.
While restraint stress does not activate LepRbPAG or LepRbPBN
cells, it activates LepRbEW cells (27). Since LepRb is ablated from
LepRbEW cells in LepRbCCKKO mice, but the glycemic response to
restraint stress is not altered in these animals (8), LepRbEW cells must
modulate different outputs than do LepRbPAG and LepRbPBN cells.
Indeed, projections from EW cells target the striatum (28, 29) rather
than the VMN, suggesting a potential role for LepRbEW cells in modulating motivated behaviors, rather than metabolic fuel mobilization.
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Figure 6. Deleting LepRb in the PAG exaggerates hyperglycemic responses to formalin
and respiratory responses to hypercapnia. (A)
Leprfl/fl mice on the Cre-inducible eGFP-L10a
background were injected with AAV-Cre into
the PAG to generate LepRbPAGKO mice (n = 13,
control; 14, LepRbCCKKO). Body weight (B)
and food intake (C) of control-injected and
LepRbPAGKO mice were monitored weekly. In
separate experiments, mice were treated with
(D) glucose (2 g/kg, i.p.), (E) insulin (1.2 U/kg,
i.p.), (F) 2DG (250 mg/kg, i.p.), and (G) formalin
(20 μl, hind paw) and blood glucose concentrations were followed. (H) Respiratory rate was
measured at baseline and following exposure
to 3% CO2. Data are plotted as mean ± SEM;
*P < 0.05. Data in panels B–G were analyzed
using 2-way repeated-measures ANOVA with
Fisher’s LSD post hoc test. Data in panel H were
analyzed using a 1-tailed t test.

The output of the LepRbPAG→PBN→VMN circuit is largely specific for the augmentation of SNS outflow: this brain stem circuit
does not represent a mechanism by which leptin modulates food
intake, body weight, or metabolism at baseline, since none of these
parameters were altered in LepRbCCKKO or LepRbPAGKO mice. Furthermore, our data reveal that leptin action on LepRbPAG cells does
not alter noxious stimulus perception or responding, since the tailflick and withdrawal responses are not changed in the LepRbPAGKO
mice. This is consistent with our finding that pain-sensing neurons

in the spinal cord do not directly synapse
on LepRbPAG cells. In addition to noxious
stimuli and hypercapnia, it is possible that
other signals of acutely elevated metabolic
demand that are integrated by the PAG
might engage LepRbPAG neurons and their
circuitry, as well.
Leptin modulates the LepRbPAG→
PBN→VMN circuit at 2 points — the PAG
and the PBN. That the circuits downstream of LepRbPAG and LepRbPBN neurons
overlap substantially makes teleological
sense, since both circuits control similar
physiologic end points (SNS outflow and
glucose mobilization) and must therefore
converge on the same output (the VMN
in this case) to mediate their overlapping
physiologic functions. This is not dissimilar to the convergence of DMH and
arcuate nucleus (ARC) LepRb-expressing
neurons on common pathways that control food intake and overall energy expenditure. While on the surface, it may seem
redundant for leptin to act at multiple
sites within a single circuit, leptin acts at
least somewhat distinctly at these 2 sites;
PAGLepRb neurons do not contribute to
the CRR to hyperglycemia and are only
involved in responding to noxious stimuli. Thus, leptin action on
LepRbPAG cells does not alter the CRR to hypoglycemia, whereas
PBN leptin action does.
The expression of LepRb in the PAG (in addition to the PBN)
suggests that PBN LepRb on its own may not adequately augment
SNS activation and glucose mobilization in response to noxious
stimuli. If so, this could reflect the need for cell-autonomous
leptin action to modulate the cellular response to the noxious
input. While silencing all PBN neurons blocked the hyperglycejci.org   Volume 127   Number 8   August 2017
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Figure 7. PAGLepRb neurons act via the PBN to increase
blood glucose. (A) LeprCre mice were injected with AAVhM3dq in the PAG and either a GFP-expressing control virus
(n = 7) or AAV-TetTOX-GFP (n = 10) to constitutively express
GFP or GFP plus TetTOX in the PBN, respectively. All mice
were randomly assigned to receive vehicle control or CNO;
mice received the other treatment the following week (B
and C). Glycemic responses following vehicle injection were
not different between groups and were thus combined
into a single control group. (D) Our data demonstrate that
PAGLepRb neurons act via the PBN to mobilize glucose and
increase adrenal SNA when activated by noxious stimuli
such as pain and hypercapnia. In the presence of sufficient
energy stores, leptin inhibits these neurons to limit sympathetic activation and hyperglycemia to appropriate levels
during the response to noxious stimuli. When energy stores
are depleted, however, loss of leptin inhibition of PAGLepRb
neurons augments sympathetic and glycemic responses
to noxious stimuli to ensure a sufficient glucose mobilization in response to noxious stimuli, despite reduced overall
sympathetic tone and the depletion of energy stores. Data
are plotted as mean ± SEM; groups with different letters
are significantly different. P < 0.05. Data in panel B were
analyzed using 2-way repeated-measures ANOVA with
Fisher’s LSD post hoc test. Data in panel C were analyzed
using 1-way ANOVA with Fisher’s LSD post hoc test.

mic effect of activating LepRbPAG cells, silencing LepRbPBN cells
did not (data not shown); thus LepRbPAG neurons must activate
non-LepRb PBN→VMN cells as well as LepRbPBN cells to enhance
glucose mobilization in response to noxious stimuli. Indeed, formalin activates a large number of non-LepRb PBN neurons that lie
in the vicinity of LepRbPBN neurons, consistent with the notion that
LepRbPBN cells represent only a subset of the PBN cells that make
up the circuit downstream of LepRbPAG neurons.
While the similar results of activating LepRbPAG neurons and
removing LepRb from these cells suggests that the lack of leptin
signaling activates LepRbPAG neurons (i.e., that leptin inhibits
LepRbPAG neurons), leptin and fasting each fail to detectably alter
the activity of LepRbPAG cells by c-Fos immunohistochemistry;
3110
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neither does leptin alter that activity of LepRbPAG
neurons in ex vivo slice preparations (data not
shown). We previously observed that leptin inhibits LepRbPBN cells under low-glucose conditions
(8), but we were unable to detect leptin-mediated
inhibition of these cells in normal glucose, suggesting that a relevant activating stimulus might be
required to observe the inhibitory effect of leptin on
these cells. Hence, the effect of leptin on LepRbPAG
cells might also be detectable only during activation of the neurons by other stimuli (e.g., by pain
or hypercapnia). Unfortunately, it is not possible
to stimulate ex vivo slice preparations with pain or
hypercapnia, since the neurons that initially detect
these stimuli lie remote to the LepRbPAG cells. Thus,
leptin might inhibit LepRbPAG neurons, but technical issues prevent us from detecting this change in
ex vivo slices. Since LepRbPAG neurons are largely
glutamatergic (data not shown), the activation of
these cells by leptin could also stimulate an inhibitory interneuron to mediate the observed effects. It is also possible that leptin
does not directly or acutely alter the firing rate of LepRbPAG neurons, but rather mediates a transcriptional change that alters the
magnitude of the response evoked by activating stimuli. Additionally, it is theoretically possible that the PAG could contain
multiple subtypes of LepRb neurons.
Despite the power and utility of the genetic tools that we have
employed to dissect the function of LepRbPAG neurons, it must be
recognized that these manipulations are artificial and extreme;
the level of activation, silencing, or degree of leptin insensitivity that these tools produce is unlikely to be recapitulated under
physiologic circumstances. Nonetheless, the consistency of the
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results produced by the various approaches undertaken suggests
the veracity of our conclusions.
In addition to revealing the function of the largest population
of LepRb neurons in the brain stem (LepRbPAG neurons), which
had not, to our knowledge, previously been studied, our findings
define a new component of the response to fasting and a new physiologic role for leptin: in addition to the hypothalamically mediated
energy-sparing neuroendocrine response to starvation, low leptin
augments the activation of a LepRbPAG→PBN→VMN circuit that
ensures adequate SNS drive and glucose mobilization to meet the
metabolic needs associated with noxious stimuli or hypoglycemia
during negative energy balance. In the future, it will be important to
identify other stimuli that act via this system to augment SNS outflow during negative energy balance as well as to define the detailed
mechanisms by which this circuit mediates glucose mobilization.

Methods

Animals. All mice were provided with food and water ad libitum unless
noted otherwise and kept in a temperature-controlled room on a
12-hour light/12-hour dark cycle. All experiments were carried out
using approximately equal numbers of male and female mice. Animals
were processed and studied in the order of their randomly assigned
ear tags. Investigators were blinded to the genotype and/or treatment
for all studies. All mice were genotyped via PCR across the potentially mutated region prior to study. C57BL/6 animals originated from
Jackson Laboratories, but all other mice were bred within our colony.
LeprCre/Cre mice were on a C57BL/6 background, as previously described
(8, 30–32). LepRbeGFP-L10a mice were generated by interbreeding compound homozygous LeprCre/Cre Rosa26eGFP-L10a/eGFP-L10a mice. LepRbeYFP
mice were generated by interbreeding compound homozygous
LeprCre/Cre Rosa26eYFP/eYFP mice. LepRbCCKKO mice and their controls
were generated by breeding male CckCre Leprfl/fl mice to female Leprfl/fl
mice. Leprfl/fl mice for AAV-Cre injection were generated by interbreeding homozygous Leprfl/fl mice. When possible, animals were randomly
assigned to groups and investigators were blind to treatment.
Reagents. The AAV-map2c-dsRed was developed by cloning the
coding sequences for the map2c-dsRed fusion protein (in reverse orientation) into the base Cre-inducible AAV vector, using SacI and NheI
restriction sites. AAV-map2c-dsRed stocks were prepared at the University of North Carolina (UNC) Vector Core (Chapel Hill, North Carolina, USA). The AAV-Syn-GFP and AAV-TVA+G helper viruses were
previously described (33, 34); viral stocks were prepared at the UNC
Vector Core. The Rabies-ΔG-mCherry was as previously described
(18, 34) and was generated at the University of Michigan Viral Vector
Core with the support of the Molecular Genetics core of the Michigan
Diabetes Research Center (University of Michigan). AAV-hM3dq,
AAV-mCherry, AAV-GFP, and AAV-Cre were purchased from the
UNC vector core. AAV-TetTox-GFP was from the Stanford University
Viral Vector Core (Stanford, California, USA).
Perfusion and immunohistochemistry. Brains were collected and
processed as previously described (8). To reveal leptin-responsive
neurons by pSTAT3, leptin was administered (5 mg/kg, i.p.) 2 hours
prior to perfusion. For c-Fos studies, mice were exposed to a given
stimulus 90 minutes prior to perfusion. After either stimulus exposure
or leptin administration, mice were anesthetized with avertin prior
to transcardial perfusion with PBS followed by 10% formalin. Brains
were removed and placed into 10% formalin overnight, followed by
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30% sucrose for at least 1 day. Brains were cut into 30-μm sections
on a freezing microtome in 4 series and stored in antifreeze solution (25% ethylene glycol, 25% glycerol). Sections were washed with
PBS and then treated sequentially with 1% hydrogen peroxide/0.5%
sodium hydroxide, 0.3% glycine, and 0.03% sodium dodecyl sulfate.
Pretreatment was followed by an hour in blocking solution (PBS containing 0.1% Triton X-100, 3% normal donkey serum), then overnight
incubation in blocking solution containing rabbit anti-c-Fos (sc-52,
Santa Cruz Biotechnology Inc., 1:1000) and/or chicken anti-GFP
(GFP-1020, Aves, 1:1000), rabbit anti-dsRed (632496, Living Colors, 1:1000), rabbit anti-pSTAT3 (91455, Cell Signaling Technology,
1:500), or rabbit anti-calcitonin gene-related peptide (anti-CGRP)
(PC205L, Millipore, 1:1000) at room temperature. The next day,
the sections were incubated with fluorescent secondary antibodies
(Molecular Probes, 1:200) or with biotinylated secondary antibody
(Jackson Immunoresearch, 1:200) followed by ABC amplification
(Vector Laboratories, 1:500) and diaminobenzadine (Thermo Scientific) reaction. The sections treated with biotinylated secondary
antibody were exposed to avidin/biotin complex solution followed by
diaminobenzadine reaction. The sections were mounted onto slides
coverslipped with Fluoromount-G (Southern Biotech). Images were
collected on an Olympus Bx53 microscope, and the number of immunoreactive cells were counted using Adobe photoshop. The number
of c-Fos–positive nuclei colocalizing with GFP-expressing cells were
counted, along with total GFP-containing cells, and were expressed as
a percentage of all GFP-expressing cells within the region of interest.
Phenotypic studies. Body weight and food intake were monitored
weekly in animals starting at 3 weeks after surgery. Glycemic measures, including glucose tolerance test (GTT) (2 g/kg body weight,
i.p.), insulin tolerance test (ITT) (1.2 unit/kg body weight, Humulin,
Eli Lilly, i.p.), 2DG (Sigma-Aldrich) challenge (250 or 500 mg/kg body
weight, ip), and formalin challenge (20 μl; 5% formalin, intra–hind
paw) were determined in 12- to 18-week-old animals by analyzing tail
vein blood with a OneTouch Ultra 2 glucometer (Johnson & Johnson).
For formalin challenge, mice were not included in the study unless
there was visual inspection confirming inflammation of the hind paw
to control for a missed injection. To measure leptin-induced pSTAT3,
animals were fasted for 24 hours prior to leptin administration. For
fasting modulation of hyperglycemic responses to intra–hind paw formalin injection, mice were fasted for 12 hours. For DREADD studies,
CNO (Tocris Biosciences) was administered via i.p. injection at 0.3
mg/kg body weight.
Stereotaxic injections. Eight- to fourteen-week-old animals were
anesthetized with 1.5%–2% isoflurane in preparation for craniotomy.
The skull was exposed, bregma and lambda were leveled, a hole was
drilled, and we injected the contents of a pulled pipette at the coordinates of our target for approximately 25 nl/min. For the PBN, 100 nl of
virus was injected at anteroposterior (AP) –4.85, mediolateral (ML) ±
1.2, and dorsoventral (DV) –3.3. For the PAG, 100 nl of virus was injected at 4 separate coordinates per animal (AP: –4.9, ML: 0, DV: 0.7; AP:
–4.8, ML: ± 0.6, DV: 0.95; AP: –4.7, ML: 0, DV: 0.8). For the VMN, 50
nl was injected at AP: –1.1, ML: ± 0.35, DV: –3.3. After 5 minutes, to
allow the virus to diffuse into the brain, the pipette was raised slowly
out of the hole in the skull, the hole in the skull was filled with bone
wax, and the skin was closed with surgical sutures (Henry Schein).
Analgesics were administered prophylactically to all mice to prevent
postsurgical pain. The animals were allowed 4 weeks to recover from
jci.org   Volume 127   Number 8   August 2017
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surgery before experimental manipulation. At 3 weeks after surgery,
the animals were individually housed for experiments that included
body weight, food intake, and glycemic analyses. For tracing studies,
mice were euthanized at different times after injection depending on
the virus (rabies, 1 week; map2c-dsRed/Syn-GFP, 2 weeks). We used
fluorescent reporters to confirm injection of the virus into the target
brain region in all studies; if the fluorescence was not observed within
the region of interest or leaked into another region containing LepRb
neurons, these cases were omitted from analyses. In the case of rabies
tracing, the VMN injection site was confirmed by visualizing inflammation and the needle track 1 week after injection, since the pseudotyped rabies virus requires TVA expression for initial viral entry and
TVA expression was restricted to the PBN.
Adrenal SNA. Adrenal SNA was assessed using multifiber nerve
recording. Mice (14 to 20 weeks old) that received the DREADDhM3dq virus in either the PAG or PBN were initially anesthetized
with i.p. administration of ketamine (91 mg/kg body weight) and xylazine (9.1 mg/kg body weight). Intubation with PE-50 was performed
to provide an unimpeded airway for the mouse to spontaneously
breathe O2-enriched room air. Micro-renathane tubing (MRE-40,
Braintree Scientific) was inserted into the right jugular vein for infusion of the sustaining anesthetic agent: α-chloralose (initial dose: 12
mg/kg, then sustaining dose of 6 mg/kg/h). Another MRE-40 tubing
was inserted into the left carotid artery for continuous measurement
of arterial pressure and heart rate. Core body temperature was maintained at 37.5°C. A retroperitoneal incision was made to gain access to
the preganglionic nerve fibers that innervate the left adrenal gland.
A single multifiber nerve filament was carefully placed on a bipolar
platinum-iridium wire (40 gauge, A-M Systems) and then sealed with
silicone gel (Kwik-Sil, WPI). The adrenal nerve signal (AdSNA) was
amplified 105 times, with low- and high-frequency filter cutoffs at 100
and 1 Khz, respectively. The amplified and filtered signal was routed
to a data acquisition system (MacLab Model 8s), which counted the
number of nerve spikes that exceeded a threshold level set just above
the noise level each second. After allowing all hemodynamic parameters to stabilize, a slow i.v. infusion of CNO was given over 60 seconds
and adrenal SNA was continuously monitored for the next 30 minutes. Next, a slow infusion of vehicle (hydroxypropyl β cyclodextrin;
5 μl/g body weight, i.v.) was given over 60 seconds and the adrenal
SNA was continuously measured for next 30 minutes. Background
noise was excluded in the assessment of adrenal SNA by correcting
for postmortem activity.
Behavioral analyses. Activity of 18- to 22-week-old mice was determined in the open-field test. The mice were introduced to the openfield chamber for 2 hours prior to experimentation. On the following
day, the mice were introduced to the chamber for 1 hour of baseline
measurement followed by activity recording 1 hour after injection.
Data were analyzed as the total number of counts over this 1-hour period. Tail flick and hind paw latency were tested as previously described
using a tail-flick test analgesia meter (IITC Life Science) (35). For the
tail-flick test, mice were individually restrained during the test to
determine the latency to remove the tail away from a 75-degree light
on 3 separate instances; the average of the 3 instances was used as an
individual data point. For the hind paw test, the mice were allowed
to acclimate to a Plexiglass chamber for 1 hour prior to testing. The
75-degree light was then concentrated on the hind paw of an immobile
mouse, and the latency for the hind paw to move away from the light
3112
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was recorded (36). As with the tail-flick test, 3 separate instances of
this test were recorded and averaged for an individual data point.
Respiratory measurement. Baseline ventilation and the ventilatory
response to hypercapnia were measured in freely moving, conscious
14- to 18-week-old mice using a whole-body plethysmograph (Emka
Technologies). Gas tanks of O2, N2, and CO2 were connected to the plethysmograph and digitally controlled by the plethysmograph to deliver
gas mixtures into each plethysmograph mouse chamber. Each mouse
was placed inside the chamber for 20 minutes to acclimate. After
acclimation, baseline ventilation was measured while the mice were
exposed to room air (e.g., 21% O2, 79% N2, 0% CO2). To determine
the ventilatory response to hypercapnia, the CO2 concentration inside
the chamber was elevated to 3% for periods of 4 minutes, separated
by 5-minute recovery periods in room air (similar to ref. 37), while
real-time breathing frequency was recorded. As CO2 was increased,
N2 was decreased to allow O2 levels to be stabilized at 21%. In total,
mice remained in the plethysmograph for approximately an hour. All
respiratory measures were recorded between 8 am and 1 pm. During
recording, mice were continuously monitored by the investigator to
ensure that they stayed awake (as the ventilation response is blunted
by sleep; ref. 37). If a mouse fell asleep, the investigator aroused the
animal by gently tapping on the chamber.
Statistics. Statistical methods were not used to predetermine
sample sizes, but our sample sizes are similar to those in previously
published studies using similar approaches (8, 17, 37–39). Sample
sizes for groups that involved stereotaxic injection of specific populations of cells were 40% larger than for other groups to account for
a 50%–60% bilateral hit rate. c-Fos data and activity data were analyzed by 1-tailed t test. Blood glucose data were analyzed by 2-way
repeated-measures ANOVA with Fisher’s least significant difference
(LSD) post hoc test. Adrenal SNA data were analyzed by 1-tailed t test
of 5-minute bins across the experiment. No data were removed unless
the injection was a miss or the animal was sick or injured at the time
of the experiment (loss of >10% body weight). Data that did not fall
under a normal distribution or equal variance were log transformed,
then reanalyzed. Significance was set at P ≤ 0.05. All data were analyzed using SigmaStat (Systat).
Study approval. The procedures included in this manuscript were
approved by the appropriate Committees on the Use and Care of Animals at the University of Michigan and the University of Iowa.
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